Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
84.7M
-
Shares change
-
-588K
-
Total reported value, excl. options
-
$2.34B
-
Value change
-
-$26.2M
-
Put/Call ratio
-
0.27
-
Number of buys
-
99
-
Number of sells
-
-103
-
Price
-
$27.67
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2021
265 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2021.
Evolent Health, Inc. - Class A Common Stock (EVH) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.7M shares
of 112M outstanding shares and own 75.86% of the company stock.
Largest 10 shareholders include Engaged Capital LLC (7.83M shares), VANGUARD GROUP INC (7.55M shares), JPMORGAN CHASE & CO (6.1M shares), BlackRock Inc. (5.89M shares), Granahan Investment Management, LLC (5M shares), FMR LLC (4.15M shares), DIMENSIONAL FUND ADVISORS LP (3.3M shares), CREDIT SUISSE AG/ (2.9M shares), Bellevue Group AG (2.61M shares), and BLAIR WILLIAM & CO/IL (2.48M shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.